PubMed Health⌕ Search

Biomedical subjects

G Schön

Publications and source records attributed to G Schön.

At least 19 recordsLinked to original sources
PubMed2003

Kondo effect in the presence of itinerant-electron ferromagnetism studied with the numerical renormalization group method.

The Kondo effect in quantum dots (QDs)-artificial magnetic impurities-attached to ferromagnetic leads is studied with the numerical renormalization group method. It is shown that the QD level is spin split due to the presence of ferromagnetic electrodes, leading to a suppression of the Kondo effect. We find that the Kondo effect can be restored by compensating this splitting with a magnetic field. Although the resulting Kondo resonance then has an unusual spin asymmetry with a reduced Kondo temperature, the ground state is still a locally screened state, describable by Fermi liquid theory and a generalized Friedel sum rule, and transport at zero temperature is spin independent.

Journal Article↗
PubMed2003

Kondo effect in quantum dots coupled to ferromagnetic leads.

We study the Kondo effect in a quantum dot coupled to ferromagnetic leads and analyze its properties as a function of the spin polarization of the leads. Based on a scaling approach, we predict that for parallel alignment of the magnetizations in the leads the strong-coupling limit of the Kondo effect is reached at a finite value of the magnetic field. Using an equation of motion technique, we study nonlinear transport through the dot. For parallel alignment, the zero-bias anomaly may be split even in the absence of an external magnetic field. For antiparallel spin alignment and symmetric coupling, the peak is split only in the presence of a magnetic field, but shows a characteristic asymmetry in amplitude and position.

Journal Article↗
PubMed2002

Electrical transport through single-molecule junctions: from molecular orbitals to conduction channels.

We present an atomistic theory of electronic transport through single organic molecules that reproduces the important features of the current-voltage ( I-V) characteristics observed in recent experiments. We trace these features to their origin in the electronic structure of the molecules and their local atomic environment. We demonstrate how conduction channels arise from the molecular orbitals and elucidate the contributions of individual orbitals to the current. We find that in thiol-bridged aromatic molecules many molecular orbitals contribute to a single conduction channel and discuss the implications of this result for the design of molecular devices.

Journal Article↗
PubMed2002

Subharmonic shapiro steps and assisted tunneling in superconducting point contacts.

We analyze the current in a superconducting point contact of arbitrary transmission in the presence of a microwave radiation. The interplay between the ac Josephson current and the microwave signal gives rise to Shapiro steps at voltages V = (m/n)h(omega)(r)/2e, where n,m are integer numbers and omega(r) is the radiation frequency. The subharmonic steps (n not equal 1) are a consequence of multiple Andreev reflections (MAR) and provide a signature of the peculiar ac Josephson effect at high transmission. Moreover, the dc current exhibits a rich subgap structure due to photon-assisted MARs.

Journal Article↗
PubMed2001

Superconducting single-charge transistor in a tunable dissipative environment.

We study a superconducting single-charge transistor, where the coherence of Cooper pair tunneling is destroyed by the coupling to a tunable dissipative environment. Sequential tunneling and cotunneling processes are analyzed to construct the shape of the conductance peaks and their dependence on the dissipation and temperature. Unexpected features are found due to a crossover between two distinct regimes, one "environment assisted" the other "environment dominated." Several of the predictions have been confirmed by recent experiments. The model and results apply also to the dynamics of Josephson junction quantum bits on a conducting ground plane, thus explaining the influence of dissipation on the coherence.

Journal Article↗
PubMed1998

Three-dimensional navigation in otorhinolaryngological surgery with the viewing wand.

We report our experiences with the ISG Viewing Wand intraoperative 3-dimensional navigation device in endonasal endoscopic procedures of the paranasal sinuses, anterior skull base, and petrous bone. In the last 12 months we have routinely used the wand in 90 patients for treatment of polyposis nasi, for biopsies and removal of tumors in the nasal cavity and at the frontal skull base, for endocrine ophthalmopathy, and in 1 case for cholesteatoma. We present our computed tomography, magnetic resonance imaging, and clinical protocols that allow a precise routine use of the Viewing Wand. In all cases, the system was extremely helpful for intraoperative localization and helped to optimize surgery.

Equipment Design↗
PubMed1997

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

The anti-CD25 immunotoxin (IT), RFT5-SMPT-dgA, was used in a phase I dose escalation trial in patients with refractory Hodgkin's lymphoma. The IT was constructed by linking the monoclonal antibody RFT5 via a sterically hindered disulfide linker to deglycosylated ricin-A. All patients in this trial were heavily pretreated with a mean of 5 (range, 2 to 8) different prior therapies, including autologous bone marrow transplantation in 8 of 15. The mean age was 29 years (range, 19 to 34 years). Thirteen of 15 patients had advanced disease (stage IV) with massive tumor burdens and 6 of 15 had B symptoms. The IT was administered intravenously over 4 hours on days 1, 3, 5, and 7 for total doses per cycle of 5, 10, 15, or 20 mg/m2. Patients received one to four cycles of treatment. The peak serum concentration of intact IT varied from 0.2 to 9.7 micrograms/mL. The serum half life (T1/2) of the IT ranged from 4.0 to 10.5 hours (mean, 6.1 hours). Side effects were related to vascular leak syndrome (VLS), ie, decreases in serum albumin, edema, weight gain, hypotension, tachycardia, myalgia, and weakness. Two patients had a National Cancer Institute (NCI) grade 2 allergic reaction with generalized urticaria and mild bronchospasm. At 15 mg/m2, 1 patient experienced a grade 3 myalgia. All 3 patients receiving 20 mg/m2 experienced NCI grade 3 toxicities (edema, nausea, dyspnea or tachycardia) and 1 patient had NCI grade 4 myalgia. Thus, the maximal tolerated dose was 15 mg/m2. Seven of 15 patients made human antiricin antibodies (> or = 1.0 microgram/mL) and 6 of 15 developed human antimouse antibodies (> or = 1.0 microgram/mL). Clinical response included 2 partial remissions, 1 minor response, 3 stable diseases, and 9 progressive diseases. As has been predicted from the preclinical tests, these data seem to indicate clinical efficacy of this new IT in heavily pretreated Hodgkin's patients, thus warranting further clinical investigation.

Adult↗